Mio

20歳｜大学生｜勉強と趣味の両立が永遠のテーマ。 好きなものを好きなだけ。

[Mio @mio_log_]

コンビニのコピー機の横に台本の忘れ物。
ページに「早瀬夏海 → 幸後一香」って書いてある。
…これ見ちゃって大丈夫なやつ？

[NeuroPace @NeuroPace]

Living with epilepsy is a lot more complex than people may think.

If you’re still having seizures despite medication, it may be time to explore the RNS® System.

Take this 2-minute quiz to see if a personalized treatment option may be right for you: https://t.co/fUfVj36ch8

[Mio @mio_log_]

POG豆知識。

ピースワンデュック、サノノグレーター。

父グレーターロンドン、母父ジャングルポケットはニックス配合なんよ。

#ピースワンデュック #サノノグレーター #グレーターロンドン #ジャングルポケット

[Mio @mio_log_]

@JRA_JRA_JRA コンファロニエーレじゃなくてゴンファロニエーレな。
戸崎さんに謝れ。

[NeuroPace @NeuroPace]

Attending ASSFN? Join NeuroPace for our Breakfast Symposium on Mon, June 1 at 7 AM.



We’ll discuss Responsive Thalamic Neuromodulation, 18-month Nautilus data, & our LGS Feasibility Study with Drs. Rolston, Richardson, & Morrell.



Space is limited—RSVP here: https://t.co/A5NLRf4lsg

CAUTION - Investigational device. Limited by United States law to investigational use for Idiopathic Generalized Epilepsy (IGE) and Lennox-Gastaut Syndrome (LGS).

Rx Only. The RNS® System is an adjunctive therapy for adults with refractory, partial onset seizures with no
more than 2 epileptogenic foci. See important safety information at https://t.co/phw9TTn5jG

[NeuroPace @NeuroPace]

ASSFN Fellows! Join NeuroPace for an exclusive networking dinner on Sat, May 30 at 6:00 PM.



Connect with colleagues and discuss strategies for building your neuromodulation practice post-fellowship.



This event is limited to just 30 seats. Reserve yours here: https://t.co/ooy6egGYdn

Invite Link:
https://t.co/ooy6egGYdn

Registration Link:
https://t.co/cIMt76FTcg

[NeuroPace @NeuroPace]

Remembering those who gave their lives in service.
#MemorialDay #HonorAndRemember

[NeuroPace @NeuroPace]

We are on the floor at ASSFN! Stop by Booth #107 to connect with the clinical team, and learn more about the RNS® System for drug-resistant focal epilepsy.



See you there!

Rx Only. The RNS® System is an adjunctive therapy for adults with refractory, partial onset seizures with no more than 2 epileptogenic foci. See important safety information at https://t.co/phw9TTn5jG

[NeuroPace @NeuroPace]

The RNS® System Post-Approval Study, now published in @GreenJournal, reveals sustained long-term outcomes for drug-resistant focal epilepsy.

See the full study results: https://t.co/tvLXuhv06k

RNS System Safety Info: https://t.co/StMsbqNwyY

[NeuroPace @NeuroPace]

In The Pitt Season 2 finale, Dr. Al-Hashimi's "neuromodulation device which can sense and stop the seizures almost immediately" — that’s a real description of how the RNS® System from NeuroPace works.

#RNSSystem #Epilepsy #NeuroPace #ThePitt

RNS System Safety Info: https://t.co/phw9TTn5jG

https://t.co/I2Q3I6a5wW

[NeuroPace @NeuroPace]

#Seizures can affect everyday independence, including the ability to drive. 🚗 The RNS® System stops seizures at the source, helping you get back to more of life’s everyday moments.*➡️ Take the quiz to see if the RNS System might be right for you: https://t.co/oL16fzR52D

Safety Info: https://t.co/phw9TTn5jG

*Every person’s seizures are different and individual results will vary.

#epilepsy #seizures #epilepsyawareness

[NeuroPace @NeuroPace]

Q1 2026 results: $22.1M in revenue, RNS System revenue up ~20% YoY 📈; Full year guidance raise; Strong operating leverage.

Continued RNS System growth and a clear roadmap ahead across market, clinical, and product development.

Full release + webcast → https://t.co/8fRgD6JRWD

#NPCE #NeuroPace #MedTech #Epilepsy

[Mio @mio_log_]

@momo_dh_room 米国株だとNeuropace Incがおすすめです

[NeuroPace @NeuroPace]

To the moms living with epilepsy—and the moms who care for someone who does—
Your strength inspires us. 💐

Happy Mother’s Day.

#MothersDay #EpilepsyMoms

[Mio @mio_log_]

@anal_city Neuropace一択です

[NeuroPace @NeuroPace]

Epilepsy treatment is not one size fits all. If your anti-seizure meds are not working, it may be time to learn about a different treatment option. Join our free webinar to ask an #epilepsy specialist during our Q&A session: https://t.co/ghnYcIQt7M

🗓️Free webinar: Tue 5/12, at 5pm PT/8pm ET

Safety Info: https://t.co/phw9TTn5jG

[NeuroPace @NeuroPace]

Attending ASSFN? Join NeuroPace for our Breakfast Symposium on Mon, June 1 at 7 AM.



We’ll discuss Responsive Thalamic Neuromodulation, 18-month Nautilus data, & our LGS Feasibility Study with Drs. Rolston, Richardson, & Morrell.



Space is limited—RSVP here: https://t.co/A5NLRf4lsg

CAUTION - Investigational device. Limited by United States law to investigational use for Idiopathic Generalized Epilepsy (IGE) and Lennox-Gastaut Syndrome (LGS).

Rx Only. The RNS® System is an adjunctive therapy for adults with refractory, partial onset seizures with no
more than 2 epileptogenic foci. See important safety information at https://t.co/phw9TTn5jG

[NeuroPace @NeuroPace]

ASSFN Fellows! Join NeuroPace for an exclusive networking dinner on Sat, May 30 at 6:00 PM.



Connect with colleagues and discuss strategies for building your neuromodulation practice post-fellowship.



This event is limited to just 30 seats. Reserve yours here: https://t.co/ooy6egGYdn

Invite Link:
https://t.co/ooy6egGYdn

Registration Link:
https://t.co/cIMt76FTcg

[NeuroPace @NeuroPace]

#NursesWeek To every nurse supporting people with epilepsy—you make a difference every day.

Thank you for the compassion, care, and commitment. 🩺💜

#ThankYouNurses #EpilepsyCare

[NeuroPace @NeuroPace]

Long-term efficacy is a critical goal in treating drug-resistant epilepsy. See the newly published 3-year results from the RNS® System Post-Approval Study.

Review the full study here: https://t.co/tvLXuhv06k

RNS System Safety Info: https://t.co/StMsbqNwyY

[Mio @mio_log_]

@realgaiginman Neuropace Inc